Analysis of Th1/Th2 response pattern for erythrodermic psoriasis

Rosenbach M, Hsu S, Korman NJ, et al. Treatment of erythrodermic psoriasis: from the medical board of the National Psoriasis Foundation. J Am Acad Dermatol, 2010, 62(4):655–662

Zattra E, Belloni Fortina A, Peserico A, et al. Erythroderma in the era of biological therapies. Eur J Dermatol, 2012,22(2):167–171

Zhu K, Ye J, Wu M, et al. Expression of Th1 and Th2 cytokine-associated transcription factors, T-bet and GATA-3, in peripheral blood mononuclear cells and skin lesions of patients with psoriasis vulgaris. Arch Dermatol Res, 2010,302(7):517–523

Eyerich S, Onken AT, Weidinger S, et al. Mutual antagonism of T cells causing psoriasis and atopic eczema. N Engl J Med, 2011,21,365(3):23

Brandt EB, Sivaprasad U. Th2 cytokines and atopic dermatitis. Clin Cell Immunol, 2011,2(3):110

Li LF, Sujan SA, Yang H, et al. Serum immunoglobulins in psoriatic erythroderma. Clin Exp Dermatol, 2005, 30(2):125–127

Nickoloff BJ. The immunologic and genetic basis of psoriasis. Arch Dermatol, 1999,135(9):1104–1110

Szegedi A, Aleksza M, Gonda A, et al. Elevated rate of T-helper 1 (Th1) lymphocytes and serum IFN-gamma levels in psoriatic patients. Immunol Lett, 2003,86(3):277–280

Cousins DJ, Lee TH, Staynov DZ. Cytokine coexpression during human Th1/Th2 cell differentiation: direct evidence for coordinated expression of Th2 cytokines. J Immunol, 2002,169:2498–2506

Abdallah MA, Abdel-Hamid MF, Kotb AM, et al. Serum interferon-gamma is a psoriasis severity and prognostic marker. Cutis, 2009,84(3):163–168

Lee RE, Gaspari MT, Lotze AE, et al. Interleukin-2 and psoriasis. Arch Dermatol, 2001,124:1811–1815

Zalewska A, Wyczółkowska J, Dziankowska-Bartkowiak B, et al. Interleukin 4 plasma levels in psoriasis vulgaris patients. Med Sci Monit, 2004,10(4):CR156–162

Michel G, Mirmohammadsadegh A, Ollas E, et al. Demonstration and functional analysis of IL-10 receptors in human epidermal cells: decreased expression in psoriation by an antipsoriatc gluccocorticoid in normal cultured keratinocytes. J Immunol, 1997,159:6291–6297

Asadullah K, Sterry W, Stephanek K, et al. IL-10 is a key cytokine in psoriasis. Proof of principle by IL-10 therapy: a new therapeutic approach. J Clin Invest, 1998,101(4):783–794

Smart JM, Horak E, Kemp AS, et al. Polyclonal and allergen-induced cytokine responses in adults with asthma: resolution of asthma is associated with normalization of IFN-gamma responses. J Allergy Clin Immunol, 2002,110(3):450–456

Arakawa S, Hatano Y, Katagiri K. Differential expression of mRNA for Th1 and Th2 cytokine associated transcription factors and suppressors of cytokine signaling in peripheral blood mononuclear cells of patients with atopic dermatitis. Clin Exp Immunol, 2004,135:505–510

Ghoreschi K, Mrowietz U, Röcken M. A molecule solves psoriasis? Systemic therapies for psoriasis inducing interleukin 4 and Th2 responses. J Mol Med (Berl), 2003,81(8):471–480

Lametschwandtner G, Biedermann T, Schwarzler C, et al. Sustained T-bet expression confers polarized human TH2 cells with TH1-like cytokine production and migratory capacities. J Allergy Clin Immunol, 2004,113:987–994

Seki N, Miyazaki M, Suzuki W, et al. IL-4 induced GA-TA-3 expression is a time-restricted instruction switch for Th2 cell differentiation. J Immunol, 2004,172:6158–6166

Hultgren OH, Averring M, Stokowski A. T-box transcription-factor-deficient mice display increased joint pathology and failure of infection control during staphylococcal arthritis. Microbes Infect, 2004,6(6):529–535